<DOC>
	<DOCNO>NCT02730364</DOCNO>
	<brief_summary>The purpose study assess short term efficacy Theraflu Night powder oral solution Russian population `` Short term relief symptom cold , chill influenza , include mild moderate pain , fever nasal congestion '' .</brief_summary>
	<brief_title>Russian Market Potential Theraflu Night Powder Oral Solution Cold Flu .</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Pheniramine</mesh_term>
	<mesh_term>Dextromethorphan</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Participants must understand provide write informed consent assessment perform , understand study procedure , willing able complete require assessment Males females ≥ 18 year Clinical diagnosis URTI diagnose investigator Mild moderate sore throat , i.e . rat 1 2 4point ordinal scale ( 0=not present , 1= mild , 2=moderate , 3=severe ) , headache ( 1 , 2 3 ) fever ( le 39°C ) or/and Nasal congestion ( block nose ) : may accompany rhinorrhea ( runny nose ) and/or sneeze Baseline Jackson TSS &gt; 8 Common cold symptom less 48 hour Use investigational drug within 30 day 5 halflives enrollment , whichever longer . Investigational drug refers drug evaluate clinical trial History know hypersensitivity study drug , excipients drug similar chemical class Pregnant nursing ( lactate ) woman , pregnancy define state female conception termination gestation , confirm positive hCG laboratory test ( &gt; 5 mIU/mL ) urine dipstick baseline Any history drug hypersensitivity , asthma , urticaria , significant allergic diathesis . Participants uncomplicated seasonal allergic rhinitis accept expect allergy season clearly one month outside enrollment/ treatment period Any history brain disease , liver disease epilepsy Any evidence uncontrolled cardiovascular ( include hypertension ) , pulmonary , renal , hepatic , gastrointestinal , hematological , endocrinological , metabolic , neurological psychiatric disease screen Subject close angle glaucoma , urinary retention , prostatic hyperplasia , pyloroduodenal obstruction , pheochromocytoma , diabetes mellitus A positive alcohol breath test positive urine drug screen medical history data indicative alcoholism , drug addiction , drug abuse within precede 2 year Subject current smoker ≥10 cigarette per day ( report equivalent smoke habit use tobacco product ) unwilling refrain smoking study site Subject current smoker ≥10 cigarette per day ( report equivalent smoke habit use tobacco product ) unwilling refrain smoking study site Subject take take within last two week dose monoamine oxidase inhibitor , antidepressant , atropine , betablocking sympathomimetic drug desferrioxamine , hepatotoxic drug , drug induce liver microsomal enzyme , ( phenytoin , carbamazepine , isoniazid rifampicin ) , neuroleptic drug , chlorzoxazone , CNS depressant drug include barbiturate , hypnotic , opioid analgesic , anxiolytic sedative , antipsychotic anticipate require medication time throughout study Subject use : Systemic topical corticosteroid ( exception HRT contraceptive steroid female ) , within 3 week prior dose Slowrelease steroid ( exception HRT contraceptive steroid female ) within 90 day prior dose Subject use follow medication within 6 hour first study drug administration , anticipate use medication time throughout study : Any inhaler , medicate confectionary , throat lozenge , throat pastille , spray , product demulcent property chew gum boil sweet mint , Any medication sore throat contain local anaesthetic , Cold product oral nasal decongestant product , Paracetamol NSAID Subject use substance abuse , herbal medicine , antihistamine homeopathic medicine within 72 hour dose anticipated require drug time throughout study Subject previously enrol current study Persons directly indirectly involved execution protocol , include first degree relative study investigator , employee clinical study site , employee CRO person relate `` Vulnerable '' individual ( defined IRB e.g . incarcerated person )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>